Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Northernvinceon Jul 31, 2020 10:49am
158 Views
Post# 31349595

🔥🔥🔥$QSC🔥🔥🔥

🔥🔥🔥$QSC🔥🔥🔥Another good stock to watch today is QUESTCAP $QSC -One of the 12 lateral flow test kit that have received the Emergency Use Autorisation by the FDA... -Best antibody test on the market coz of their technologie: coloidal gold (GOLD NANOPARTICULE in fluid)...yes gold nonaparticule!!! -Ceo director have many years of experience and connexions with biotech and big pharma - they already submited application for point of care (poc) (waiting for approval) wich will allow them to partner with "cvs" and other major drug store as well... -partnership in place with professional sport teams -clinical study : 2430 clinical patients tested - sensitivity: 100% specitivity: 98.8% -expected sale: 4 millions test by months 25$US/test... -North america exclusivity and solid print in south america - Low MC (17 millions$) -Low float stock (90 millions shares) - still under the radar -Last webinar: https://questcapinc.com/questcap-corporate-update-investor-webinar-june-2020/ Worth a full watch but you can go straight to 40 min... -Last NR: https://ceo.ca/@nasdaq/questcap-secures-exclusive-sales-rights-for-emergency -Ceo director background: https://questcapinc.com/qc_team/doug-sommerville/ Connect the dots... GLTA !!!
<< Previous
Bullboard Posts
Next >>